Article
NPM1 and FLT3-TKD mutations are enriched in patients with leukemia cutis.
Dermatology online journal - 15 Jul 2020
Karagounis Theodora K, Rotemberg Veronica, Geskin Larisa J, Jurcic Joseph G, MDAuthors George Niedt
Abstract excerpt
Leukemia cutis (LC) is a dermatologic manifestation of leukemia. Its clinical implications for the patient and the biological mechanism behind the manifestation of LC are unknown. The oncology community is increasingly utilizing mutations to classify a number of malignancies to prognosticate outcomes and to choose targeted therapies. A single-center, retrospective analysis of dermatopathology cases with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
